Minerva Neurosciences (NERV) Earnings Analysis

Minerva Neurosciences (NERV) next reports earnings on 2026-08-13, consensus EPS -0.19333 USD. Last quarter (2026-03-11) it missed with EPS -0.64 USD vs -0.11 USD est (-481.8%). It has beaten estimates in 1/2 recent quarters (50%). Trailing P/E -0.15.

Last updated 2026-07-23 · Source: FMP fundamentals + earnings calendar (company filings); consensus from sell-side analyst grades

When does NERV next report earnings?

Next earnings date2026-08-13
Consensus EPS estimate-0.19333 USD
Revenue estimaten/a

NERV earnings history — beats and misses

Quarter (report date)EPS actualEPS est.SurpriseResult
2026-03-11-0.64 USD-0.11 USD-481.8%Miss
2025-08-14-0.43 USD-0.95 USD+54.7%Beat

Beat rate: 1/2 (50%) over reported quarters with consensus data.

NERV valuation and analyst view

Trailing P/E-0.15
Trailing EPS-9.455 USD
Price / book-0.77
Dividend yield0.00%
Market cap0.03B
Analyst consensusBuy (5 buy / 2 hold / 0 sell)
Avg price target5 USD

Related research pages

Frequently asked questions

When is Minerva Neurosciences (NERV)'s next earnings date?

Minerva Neurosciences is next scheduled to report on 2026-08-13, with a consensus EPS estimate of -0.19333 USD.

Did NERV beat earnings last quarter?

In its 2026-03-11 report, NERV posted EPS of -0.64 USD versus a -0.11 USD estimate — a miss of 481.8%.

What is NERV's earnings track record?

Over the last 2 reported quarters with consensus data, NERV beat estimates 1 times (50%).

What is NERV's current P/E ratio and EPS?

NERV trades at a trailing P/E of -0.15 on trailing EPS of -9.455002027334851 USD.

What do analysts rate NERV?

Analyst consensus is "Buy" across 7 ratings (0 strong buy, 5 buy, 2 hold, 0 sell, 0 strong sell). Average 12-month price target: 5 USD.